αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib

Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological malignancies in China. In particular, advanced/refractory ovarian cancer lacks effective targeted therapies due to the immunosuppressive and proangiogenic tumor microenvironment. Mesothelin (MSLN) has been found to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Juemin, Ding, Na, Guo, Xianling, Sun, Yan, Zhang, Zhiwei, Xie, Bailu, Li, Zhong, Wang, Hui, Mao, Wei, Lin, Zhicai, Qin, Fei, Yuan, Min, Chu, Wenqi, Qin, Huanlong, Qian, Qijun, Xu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887368/
https://www.ncbi.nlm.nih.gov/pubmed/33589520
http://dx.doi.org/10.1136/jitc-2020-001162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887368/
https://www.ncbi.nlm.nih.gov/pubmed/33589520
http://dx.doi.org/10.1136/jitc-2020-001162

Ejemplares similares